Skip to main content

The Molecular Basis of Neural Memory: Part 8. Case Studies of “Neuro-mimetic” Technologies- Crimson Publishers

The Molecular Basis of Neural Memory: Part 8. Case Studies of “Neuro-mimetic” Technologies by Gerard Marx in Research in Medical & Engineering Sciences

From Cajal’s [1] original studies (~1900), neurobiologists have represented neurons as “naked”, seemingly suspended in “space”. Cajal [1] overlooked issues relevant to the emergence of the memory talent from neural nets, specifically:

1. Not recognizing the morphology of the biologic neuron as relevant to its memory function.

2. Ignoring the presence of extracellular matrix (nECM), a hydrogel web/lattice entangling the extended neuron.

3. Unawareness of non-synaptic signaling between neurons through the nECM.

4. No code for emotions.

We review 2 technologies, the IBM Brain Chip and the Blue Brain Project, both which are flawed by the same oversights.

To address these flaws, we propose a tripartite mechanism, based on the dynamic interactions of 3 compartments:

1) Neurons-including glia cells/astrocytes

2) Neural extracellular matrix (nECM), a hydrogel synthesized by, and surrounding, the neurons, which performs as a “memory material”.

3) Dopants (metals + neurotransmitters (NTs)) released into the nECM, employed by the neuron to encode cognitive information with emotive context.

Effectively, this mechanism provides a psycho-chemical explanation of the encoding of emotive neural memory.

Awareness of the nECM around neurons and a molecular code for emotions, missing in both the IBM chip and the Blue Brain simulation, could lead to better modeling of mentation processes relating to neural memory. It could also aid the development of “neuro-mimetic” devices and simulations truer to neuro-biology and neuro-chemistry.

For more open access journals in crimsonpublishers Please click on link: https://crimsonpublishers.com

For more articles on Research in Medical & Engineering Sciences Please click on link:

https://crimsonpublishers.com/rmes/

Labels:

Comments

Post a Comment

Popular posts from this blog

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers   Contingent to World Health Organization (WHO) classification, myeloid sarcoma is denominated as a tumefaction comprised of myeloblasts amalgamated at an anatomical site divergent from the bone marrow which engenders distortion of normal tissue architecture. Generally, myeloid sarcoma is contemplated to be equivalent to and concurrent with acute myeloid leukaemia (AML), although lesions may occur in isolation. Additionally designated as granulocytic sarcoma, chloroma or extramedullary myeloid tumour, myeloid sarcoma categorically represents as a distinct tumefaction associated with architectural effacement of circumscribing soft tissue. Myeloid sarcoma may emerge as a de novo lesion or manifest as therapy related myeloid neoplasm or as disease progression within myeloproliferative neoplasm (MPN), myelodysplastic syndrome (MDS) or myelodysplastic / myeloproliferative neoplasm (MDS / MPN). In contrast, leukaemia cutis (LC) is...
Post a Comment
Read more

Recent Developments of Decentralized Clinical Trial Technology in Korea- Crimson Publishers

Recent Developments of Decentralized Clinical Trial Technology in Korea- CrimsonPublishers   Clinical trials are routinely performed on human participants to evaluate the safety and effectiveness of new treatments such as drugs and medical devices. Recent advances in Information and Communication Technology (ICT) have led to the development of Decentralized Clinical Trials (DCTs). DCTs allow participants to participate in various types of clinical trials without having to visit hospitals. Data collection and frequent interactions between participants and medical staff can be possible via remote monitoring environments. In addition, the costs and time for clinical trials conduction can be significantly reduced. The development of ICT-based DCT technologies has already initiated. However, the adoption of DCTs was facilitated by the coronavirus disease 2019 (COVID-19) pandemic. Interest in and research on DCTs has also grown in Korea. This study describes the present state of DCT ...
Post a Comment
Read more

Use of Thymbra Species Spreading in the Flora of Turkey for Medicinal Purposes- Crimson Publishers

Use of Thymbra Species Spreading in the Flora of Turkey for Medicinal Purposes- Crimson Publishers In terms of richness of plant species, Turkey has an important position in the world. It contains about 9,000 plant species and 11,500 taxa. Moreover, more than 1,000 plant species are used as medicinal and aromatic plants in our country. Medicinal plants are mostly evaluated by gathering from nature. Lamiaceae family covers many well-known and economically important medicinal types such as mint, sage, balm, thyme, lavender, basil. These plants, with wide adaptation limits, are well adapted to temperate and tropical regions. Although it is found in the natural flora of almost every region in our country, the Aegean and Mediterranean regions have an important position in terms of endemic species of the family. Although there are many aromatic plant species belonging to the family Lamiaceae described as thyme in Turkey, especially species containing the essential oil carvacrol and thymol ...
Post a Comment
Read more